Forest Labs Bribed Study Authors To Boost Celexa: Suit

Law360, New York (January 25, 2012, 10:19 PM EST) -- A whistleblower suit unsealed in Maryland federal court on Friday claims a Forest Laboratories Inc. unit paid kickbacks to the main author of a federally funded antidepressant drug study so he would rig it in favor of the company's drug Celexa, in violation of the False Claims Act.

The suit, originally filed by relator and psychologist H. Edmund Pigott in March, alleges that Forest paid kickbacks and bribes to Dr. John Rush of the University of Texas' Southwest Medical Center, the principal investigator of the $35...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.